Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2000
03/28/2000CA2022420C Escherichia coli vaccine
03/28/2000CA2002144C Method of preventing or reducing eosinophilia
03/28/2000CA1340934C Hepatitis b surface antigen formed by recombinant dna techniques, vaccines, diagnostics, cell lines and method of forming same
03/23/2000WO2000016061A2 Method for diagnosing the active stage of a cytomegalovirus infection in human substrates
03/23/2000WO2000015853A1 Recombinant newcastle disease virus rna expression systems and vaccines
03/23/2000WO2000015826A2 Leptin induced genes
03/23/2000WO2000015824A1 Transfer method for specific cellular localisation of nucleic acids
03/23/2000WO2000015807A1 Method for down-regulating osteoprotegerin ligand activity
03/23/2000WO2000015805A1 Use of protein kinase kiaa0551 as pharmaceutical
03/23/2000WO2000015802A1 Moraxella catarrhalis basb034 polypeptides and uses thereof
03/23/2000WO2000015801A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses
03/23/2000WO2000015798A2 Mammalian transforming growth factor beta - 9 (ztgfss9)
03/23/2000WO2000015797A2 Compositions and methods for the treatment of immune related diseases
03/23/2000WO2000015793A2 Human gpcr proteins
03/23/2000WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization
03/23/2000WO2000015790A2 Leptin induced genes
03/23/2000WO2000015788A2 Dna sequence encoding oncofetal ferritin protein
03/23/2000WO2000015784A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
03/23/2000WO2000015775A1 Rnase p polypeptides
03/23/2000WO2000015774A1 Useful properties of a bee venom protein and gene encoding same
03/23/2000WO2000015769A1 Topa
03/23/2000WO2000015767A2 Antigen-presenting cells and their use in therapy
03/23/2000WO2000015760A1 Streptococcal c beta protein compositions
03/23/2000WO2000015666A2 Compositions and methods for the treatment of tumors
03/23/2000WO2000015659A2 Stomach polypeptide zsig28
03/23/2000WO2000015259A1 Antibodies to c3b(i) for delivery of diagnostic and therapeutic agents to cancer cells
03/23/2000WO2000015258A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
03/23/2000WO2000015257A1 Vaccine preparations containing saponins
03/23/2000WO2000015256A2 Immunostimulant emulsion
03/23/2000WO2000015255A1 Vaccine against sexually transmitted diseases
03/23/2000WO2000015254A1 Immunogenic compositions and uses thereof
03/23/2000WO2000015253A1 Human chorionic gonadotropin vaccines
03/23/2000WO2000015252A1 Method of using zot or zonulin to inhibit lymphocyte proliferation in an antigen-specific manner
03/23/2000WO2000015251A2 Influenza virus vaccine composition
03/23/2000WO2000015247A2 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
03/23/2000WO2000015238A1 COMPOSITIONS OF β-GLUCANS AND SPECIFIC IGIV
03/23/2000WO2000015194A1 Calcium phosphate delivery vehicle and adjuvant
03/23/2000WO2000015175A2 Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells
03/23/2000WO2000002520A3 T-lymphocyte exchange
03/23/2000WO1999067359A3 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore
03/23/2000WO1999066025A9 Mtbx protein and nucleic acid molecules and uses therefor
03/23/2000WO1999062938A3 Polypeptides, traditionally of the human herpes virus type 8 and the diagnostic and medical application thereof
03/23/2000WO1999061085A3 Method and compositions for treatment of cancers
03/23/2000WO1999056773A9 Composition comprising tumor cells and extracts and method of using thereof
03/23/2000WO1999055876A3 Polypeptide with immunogenic properties and with a protein with modified biological functions
03/23/2000WO1999053061A3 Tumor associated nucleic acids and uses therefor
03/23/2000WO1999042588A3 Group b streptococcus antigens
03/23/2000WO1996040039A3 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
03/23/2000DE19816732A1 Diagnostik und Therapie von Erkrankungen im Zusammenhang mit HHV-8-Infektionen Diagnosis and treatment of diseases associated with HHV-8 infection
03/23/2000CA2706859A1 Mammalian transforming growth factor beta - 9
03/23/2000CA2344336A1 Vaccine preparations containing saponins
03/23/2000CA2343654A1 Method for down-regulating osteoprotegerin ligand activity
03/23/2000CA2343314A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses
03/23/2000CA2343220A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
03/23/2000CA2343051A1 Streptococcal c beta protein compositions
03/23/2000CA2343001A1 Stomach polypeptide zsig28
03/23/2000CA2342965A1 Leptin induced genes
03/23/2000CA2342833A1 Human gpcr proteins
03/23/2000CA2342771A1 Method of using zot or zonulin to inhibit lymphocyte proliferation in an antigen-specific manner
03/23/2000CA2342601A1 Antibodies to c3b(i) for delivery of diagnostic and therapeutic agents to cancer cells
03/23/2000CA2342398A1 Moraxella catarrhalis basb034 polypeptides and uses thereof
03/23/2000CA2342313A1 Immunostimulant emulsion
03/23/2000CA2342207A1 Calcium phosphate delivery vehicle and adjuvant
03/23/2000CA2341304A1 Compositions and methods for the treatment of tumors
03/22/2000EP0986636A1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells
03/22/2000EP0986577A2 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
03/22/2000EP0986572A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
03/22/2000EP0986399A1 Chelating immunostimulating complexes
03/22/2000EP0986398A1 Method for the production of vaccines against cell surface proteins
03/22/2000EP0986372A1 Vesicular complexes and methods of making and using the same
03/22/2000CN1248177A Coated particles, method of making and using
03/21/2000US6040427 A recombinant dna molecule comprising of a modified b-oligomer dimer encoding a protein that is reactive with antibodies against the wild type gene but is defective in pertussis toxin target cell receptor binding; therapy
03/21/2000US6040421 Escherichia coli O157:H7 epithelial adhesion and vaccine
03/21/2000US6040297 A therapeutic agents treating tumors and retroviral infections including hiv infections
03/21/2000US6040170 Human cytomegalovirus DNA sequences
03/21/2000US6040169 Variant strain incapable of replicating in central nervous system neurons but able to elicit a good immunological and cell mediated response
03/21/2000US6040167 Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems
03/21/2000US6040164 Amino acid sequence of enzyme which binds to calmodulin in a calcium-dependent manner and is involved in calcium signalling; for screening agonists and antagonists
03/21/2000US6040163 Amino acid sequence which couples asparagine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6040162 Amino acid sequence which couples histidine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6040157 Amino acid sequence; for angiogenesis inhibitors, antitumor agents, antiinflammatory agents, antiarthritic agents for rheumatoid arthritis, wound healing agents; treatment of diabetic retinopathy and psoriasis
03/21/2000US6040148 Heat shock protein/antigen having molecular weight of about 86 kilodaltons which induces an antibody to a breakdown product in recovering patients; for immunoassay diagnosis, immunogens and bactericides with reduced side effects
03/21/2000US6040145 Potentiation of the immune response
03/21/2000US6039970 Nasal administering bioactive drugs with hyaluronic acid derivatives, dissolving in dimethyl sulfoxide, adding to mineral oil, ethyl acetate, filtration
03/21/2000US6039959 Treatment and diagnosis of infections due to helicobacter pylori
03/21/2000US6039958 Stabilized live vaccine
03/21/2000US6039957 Oligomeric HIV-1 envelope glycoproteins
03/21/2000US6039948 Amino acid sequences with beta subunit of chorionic gonadotropin endogenous to mammals
03/21/2000US6039947 Peptides and amino acid sequences for stimulating for treatment of multiple sclerosis
03/21/2000US6039941 Live vaccine for the treatment of tumor diseases
03/21/2000CA1340931C Infectious bural disease virus
03/16/2000WO2000014257A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof
03/16/2000WO2000014253A1 Nucleic acids and proteins from pineapple stem
03/16/2000WO2000014245A1 Dengue viruses that are replication defective in mosquitos for use as vaccines
03/16/2000WO2000014244A2 Treatment of cervical cancer
03/16/2000WO2000014240A2 Attenuated salmonella sp12 mutants as antigen carriers
03/16/2000WO2000014231A1 Lim domain protein homolog
03/16/2000WO2000014228A1 Neutral amino acid transporter and gene thereof
03/16/2000WO2000014222A2 GABAB RECEPTOR SUBTYPES GABAB-R1c AND GABAB-R2 AND HETERODIMERS THEREOF
03/16/2000WO2000014220A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus
1 ... 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 ... 1823